Tisagenlecleucel vs. historical standard of care in children and young adult patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tisagenlecleucel vs. historical standard of care in children and young adult patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
Authors
Keywords
-
Journal
LEUKEMIA
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-10-25
DOI
10.1038/s41375-023-02042-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Indirect Comparison of Tisagenlecleucel and Historical Treatments for Relapsed/Refractory Diffuse Large B-cell Lymphoma
- (2022) Richard T Maziarz et al. Blood Advances
- Marketing Authorization Applications Made to the European Medicines Agency in 2018–2019: What was the Contribution of Real‐World Evidence?
- (2021) Robert Flynn et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Indirect comparison of tisagenlecleucel and blinatumomab in pediatric relapsed/refractory acute lymphoblastic leukemia
- (2021) Michael R. Verneris et al. Blood Advances
- Blinatumomab versus historical standard therapy in pediatric patients with relapsed/refractory Ph-negative B-cell precursor acute lymphoblastic leukemia
- (2020) Franco Locatelli et al. LEUKEMIA
- Tisagenlecleucel versus historical standard therapies for pediatric relapsed/refractory acute lymphoblastic leukemia
- (2020) Qiufei Ma et al. Journal of Comparative Effectiveness Research
- Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study
- (2020) Christina Peters et al. JOURNAL OF CLINICAL ONCOLOGY
- Matching-Adjusted Indirect Comparison of Blinatumomab vs. Inotuzumab Ozogamicin for Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia
- (2019) Jinlin Song et al. ADVANCES IN THERAPY
- Methods for Population-Adjusted Indirect Comparisons in Health Technology Appraisal
- (2017) David M. Phillippo et al. MEDICAL DECISION MAKING
- Epidemiologie akuter Leukämien in Deutschland
- (2017) Klaus Kraywinkel et al. Onkologe
- Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia in Adults
- (2016) Aharon Ronson et al. Current Oncology Reports
- Aktuelle Therapie der akuten lymphatischen Leukämie des Erwachsenen
- (2015) N. Gökbuget INTERNIST
- Stem-Cell Transplantation in Children With Acute Lymphoblastic Leukemia: A Prospective International Multicenter Trial Comparing Sibling Donors With Matched Unrelated Donors—The ALL-SCT-BFM-2003 Trial
- (2015) Christina Peters et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic score–based balance measures can be a useful diagnostic for propensity score methods in comparative effectiveness research
- (2013) Elizabeth A. Stuart et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- How I treat relapsed childhood acute lymphoblastic leukemia
- (2012) F. Locatelli et al. BLOOD
- Matching-Adjusted Indirect Comparisons: A New Tool for Timely Comparative Effectiveness Research
- (2012) James E. Signorovitch et al. VALUE IN HEALTH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started